KBC Securities - Hyloris Pharmaceuticals (HYL) HYLORIS - Initiation 07.08.20 - Creating value through complex drug reformulation

Report

KBC Securities

Lenny Van Steenhuyse ...

Sandra Cauwenberghs

HYLORIS - Initiation 07.08.20 - Creating value through complex drug reformulation

Today we initiate coverage on Hyloris Pharmaceuticals, an early-stage innovative specialty branded pharma company focused on adding value through the reformulation of well-known pharmaceutical drugs. As such it fills a gap in the healthcare system that has been left unaddressed by large pharma companies. Target price of â‚¬ 11.5/share and Buy rating

07/08/2020 20 EN

Underlying

Hyloris Pharmaceuticals

See profile

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Lenny Van Steenhuyse

Sandra Cauwenberghs

Other Reports on these Companies

KBC Securities

THEMATIC NOTE : BIG THINGS COME IN SMALL PACKAGES

Small-cap stocks can be smart long-term holdings, but knowing the best time to buy small-caps may even boost long-term returns. There are some smart ways for active investors to potentially enhance long-term performance by playing around with their exposure to small-cap stocks. We prove that it can be useful to choose an appropriate allocation of small-cap stock and stick to the allocation for the longer term. It can be appropriate to rebalance your portfolio, such as once per quarter or once per year. We will highlight some strategic and tactical moves investors can make to maximize returns. ...

December 9, 2020 December 9, 2020 1 EN

KBC Securities

MORNING NOTE : BCART BB, COLR BB, ECONB BB, GIMB BB, HYL BB, INGA NA, KDS NA, PROX BB, SBMO NA, TNET BB

Biocartis : Joining a powerhouse COVID-19 consortium Colruyt : Guiding for flat underlying profit growth Econocom : Interim dividend proposal of €0.12 Gimv : Invests in medical diagnostics company Biolam Hyloris : Dr Aichhorn as COO ING : Call with New CEO: focus on Costs, “clamp down” Kiadis : Feedback 1H20 call / Debt restructuring w Kreos Proximus : BIPT says commercial FttH wholesale rates are fair SBM Offshore : Prosperity is coming Various : Dynamic Top Pick List update – In: Telenet

October 1, 2020 October 1, 2020 1 EN

KBC Securities

Morning Note: ABI BB, AGS BB, COMB BB, HYL BB

AB InBev: FT rumours about CEO succession Ageas: Bid approach a non-starter, but highlights value Bois Sauvage: 1H20: Modest decrease in NAV to â‚¬Â 446.9 ps (-4.4%) Hyloris: Maxigesic IV approvals in Europe

September 8, 2020 September 8, 2020 8 EN

Morning Notes : PROX BB, WDP BB

: PROX BB, WDP BB

4h / 7m 4h / 7m 1 EN

Wim Lewi

Wim Lewi

Warehouses De Pauw 1Q24 Results, pro-active hedging lowers cost of debt

GRI 1Q24 came slightly above our expectation, but the EPRA EPS was bang in line. A remarkable metric is the decline in Cost of Debt from 1.9% to 1.7% against a backdrop of rising interest rates. WDP “over-hedged” its debt in anticipation of its investment program and raised capital. WDP repeated the FY24 EPRA EPS guidance of 1.47, slightly above our 1.46 expectation. The 5% expected yoy growth is impressive as WDP issued 5.9% new shares last November. Expired contracts (100k Sqm GLA) were reviewed with 15% uplift (under-rented). WDP recently presented its “Blend27” strategy with a guidance of...

4h / 35m 4h / 35m 1 EN

Guy Sips ... (+5)

Guy Sips
Hilde Van Boxstael
Michiel Declercq
Thibault Leneeuw
Wim Lewi

Morning Notes : GREEN BB, SIP BB, AZE BB, DEME BB

: GREEN BB, SIP BB, AZE BB, DEME BB

April 18, 2024 April 18, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

HYLORIS - Initiation 07.08.20 - Creating value through complex drug reformulation

We are a financial services provider for several types of professional clients, each with distinct needs.

THEMATIC NOTE : BIG THINGS COME IN SMALL PACKAGES

MORNING NOTE : BCART BB, COLR BB, ECONB BB, GIMB BB, HYL BB, INGA NA, KDS NA, PROX BB, SBMO NA, TNET BB

Morning Note: ABI BB, AGS BB, COMB BB, HYL BB

Morning Notes : PROX BB, WDP BB

Warehouses De Pauw 1Q24 Results, pro-active hedging lowers cost of debt

Morning Notes : GREEN BB, SIP BB, AZE BB, DEME BB

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe